| # | Drug | Count |
|---|---|---|
| 0 | ECULIZUMAB | 33 |
| 1 | ADALIMUMAB | 20 |
| 2 | OXALIPLATIN | 17 |
| 3 | ACETAMINOPHEN | 16 |
| 4 | FUROSEMIDE | 16 |
| 5 | WARFARIN | 15 |
| 6 | DROSPIRENONE AND ETHINYL ESTRADIOL | 12 |
| 7 | PREDNISOLONE | 12 |
| 8 | PREDNISOLONE ORAL | 12 |
| 9 | PREDNISOLONE ORAL SOLUTION | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ASPIRIN, ACETAMINOPHEN, CAFFEINE | 1 | 0.0294 |
| 1 | ACETAMINOPHEN, ASPIRIN, CAFFEINE | 1 | 0.0045 |
| 2 | FIBRINOGEN HUMAN | 1 | 0.0043 |
| 3 | VARDENAFIL | 1 | 0.0017 |
| 4 | MIRIKIZUMAB-MRKZ | 1 | 0.0011 |
| 5 | NORGESTREL AND ETHINYL ESTRADIOL | 1 | 0.0011 |
| 6 | NITISINONE | 1 | 0.0010 |
| 7 | GRANULOCYTE COLONY STIMULATING FACTOR | 2 | 0.0009 |
| 8 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 4 | 0.0009 |
| 9 | NORETHINDRONE AND ETHINYL ESTRADIOL | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Complement Inhibitor [EPC] | 34 |
| 1 | Corticosteroid [EPC] | 29 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 28 |
| 3 | Platinum-based Drug [EPC] | 26 |
| 4 | Kinase Inhibitor [EPC] | 21 |
| 5 | Loop Diuretic [EPC] | 17 |
| 6 | Osmotic Laxative [EPC] | 17 |
| 7 | Factor Xa Inhibitor [EPC] | 16 |
| 8 | Proton Pump Inhibitor [EPC] | 12 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vasopressin Receptor Agonist [EPC] | 1 | 0.0030 |
| 1 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 2 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 3 | Complement Inhibitor [EPC] | 34 | 0.0006 |
| 4 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 5 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 6 | Paramagnetic Contrast Agent [EPC] | 1 | 0.0002 |
| 7 | Provitamin D2 Compound [EPC] | 5 | 0.0002 |
| 8 | Bile Acid Sequestrant [EPC] | 2 | 0.0002 |
| 9 | Somatostatin Analog [EPC] | 1 | 0.0001 |